Dis-Chem Pharmacies Future Growth
Future criteria checks 3/6
Dis-Chem Pharmacies is forecast to grow earnings and revenue by 19.3% and 11.4% per annum respectively. EPS is expected to grow by 19.1% per annum. Return on equity is forecast to be 25.4% in 3 years.
Key information
19.3%
Earnings growth rate
19.1%
EPS growth rate
| Consumer Retailing earnings growth | 17.3% |
| Revenue growth rate | 11.4% |
| Future return on equity | 25.4% |
| Analyst coverage | Good |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value
Nov 10
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 2/28/2027 | 50,241 | 1,714 | 1,293 | 3,267 | 6 |
| 2/28/2026 | 44,900 | 1,464 | 997 | 2,821 | 6 |
| 2/28/2025 | 39,926 | 1,194 | 1,521 | 2,865 | 6 |
| 8/31/2024 | 37,990 | 1,061 | 843 | 1,921 | N/A |
| 5/31/2024 | 37,137 | 1,023 | 853 | 1,906 | N/A |
| 2/29/2024 | 36,283 | 984 | 863 | 1,890 | N/A |
| 11/30/2023 | 35,237 | 942 | 869 | 1,722 | N/A |
| 8/31/2023 | 34,191 | 899 | 876 | 1,555 | N/A |
| 5/31/2023 | 33,427 | 949 | 553 | 1,437 | N/A |
| 2/28/2023 | 32,664 | 1,000 | 230 | 1,320 | N/A |
| 11/30/2022 | 32,231 | 1,020 | 440 | 1,446 | N/A |
| 8/31/2022 | 31,798 | 1,040 | 650 | 1,572 | N/A |
| 5/31/2022 | 31,102 | 946 | 1,054 | 1,704 | N/A |
| 2/28/2022 | 30,407 | 853 | 1,459 | 1,836 | N/A |
| 11/30/2021 | 29,407 | 815 | 1,638 | 1,985 | N/A |
| 8/31/2021 | 28,407 | 776 | 1,817 | 2,134 | N/A |
| 5/31/2021 | 27,343 | 722 | 1,289 | 1,649 | N/A |
| 2/28/2021 | 26,278 | 669 | 762 | 1,164 | N/A |
| 11/30/2020 | 25,611 | 655 | 822 | 1,212 | N/A |
| 8/31/2020 | 24,944 | 641 | 882 | 1,260 | N/A |
| 5/31/2020 | 24,464 | 620 | 1,021 | 1,392 | N/A |
| 2/29/2020 | 23,984 | 598 | 1,160 | 1,523 | N/A |
| 11/30/2019 | 23,394 | 573 | 750 | 1,157 | N/A |
| 8/31/2019 | 22,803 | 549 | 339 | 792 | N/A |
| 5/31/2019 | 22,111 | 634 | 416 | 839 | N/A |
| 2/28/2019 | 21,420 | 719 | 493 | 887 | N/A |
| 11/30/2018 | 20,898 | 718 | 542 | 918 | N/A |
| 8/31/2018 | 20,376 | 718 | 591 | 948 | N/A |
| 5/31/2018 | 19,928 | 701 | N/A | 765 | N/A |
| 2/28/2018 | 19,480 | 684 | N/A | 581 | N/A |
| 11/30/2017 | 18,919 | 715 | N/A | 910 | N/A |
| 8/31/2017 | 18,359 | 746 | N/A | 1,239 | N/A |
| 5/31/2017 | 17,814 | 679 | N/A | 1,154 | N/A |
| 2/28/2017 | 17,268 | 612 | N/A | 1,069 | N/A |
| 11/30/2016 | 16,794 | 548 | N/A | 628 | N/A |
| 8/31/2016 | 16,320 | 484 | N/A | 187 | N/A |
| 5/31/2016 | 15,691 | 498 | N/A | 278 | N/A |
| 2/29/2016 | 15,061 | 513 | N/A | 369 | N/A |
| 2/28/2015 | 12,911 | 434 | N/A | -22 | N/A |
| 2/28/2014 | 10,321 | 409 | N/A | 455 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DCP's forecast earnings growth (19.3% per year) is above the savings rate (9.7%).
Earnings vs Market: DCP's earnings (19.3% per year) are forecast to grow slower than the ZA market (19.7% per year).
High Growth Earnings: DCP's earnings are forecast to grow, but not significantly.
Revenue vs Market: DCP's revenue (11.4% per year) is forecast to grow faster than the ZA market (3.5% per year).
High Growth Revenue: DCP's revenue (11.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DCP's Return on Equity is forecast to be high in 3 years time (25.4%)